24. Oh JH, Kim W, Park KU, Roh YH: Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations. Am J Sports Med. 2015; 43: 3062–70

25. Ornetti P, Nourissat G, Berenbaum F, Sellam J, Richette P, Chevalier X; under the aegis of the Osteoarthritis Section of the French Society for Rheumatology (Société Française de Rhumatologie, SFR). Does platelet-rich plasma have a role in the treatment of osteoarthritis? Joint Bone Spine. 2016 Jan; 83: 31–6

26. Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016; 12: 92–101

27. Sadabad HN, Behzadifar M, Arasteh F, Behzadifar M, Dehghan HR: Efficacy of Platelet-Rich Plasma versus Hyaluronic Acid for treatment of Knee Osteoarthritis: A systematic review and meta-analysis. Electron Physician. 2016; 8: 2115–22

28. Schiraldi C, Stellavato A, de Novellis F, La Gatta A, De Rosa M: Hyaluronan viscosupplementation: state of the art and insight into the novel cooperative hybrid complexes based on high and low molecular weight HA of potential interest in osteoarthritis treatment. Clin Cases Miner Bone Metab. 2016; 13: 36–7

29. Schmal H, Salzmann GM, Langenmair ER, Henkelmann R, Südkamp NP, Niemeyer P: Biochemical characterization of early osteoarthritis in the ankle. ScientificWorldJournal. 2014; 13; 434802.

30. Wainwright C, Theis JC, Garneti N, Melloh M: Age at hip or knee joint replacement surgery predicts likelihood of revision surgery. J Bone Joint Surg Br. 2011; 93: 1411–5

Fussnoten

1 TETEC AG, Reutlingen

2 Orthopädische Gemeinschaftspraxis am Ludwigsplatz, Karlsruhe